Stockreport

Armata Pharmaceuticals GAAP EPS of -$3.42, revenue of $1.1M [Seeking Alpha]

Armata Pharmaceuticals, Inc.  (ARMP) 
PDF As of December 31, 2025, Armata held approximately $14.1 million of cash and cash equivalents and restricted cash, as compared to $14.8 million as of December 31, 2024. [Read more]